Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for migraine prophylaxis
IRCT20190107042264N5Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine and chronic migraine comparing Melatonin + propranolol with Placebo + propranolol (2 arms). Primary endpoints: Migraine attack intensity and Migraine attack frequency. Started Nov 2022; status: completed.
02
Drugs
melatonin
03
Conditions
migrainechronic migraine
Beyond the preview
Go deeper on IRCT20190107042264N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190107042264N5.